US Patent 10294296 Treatment for neoplastic diseases
All edits
Edits on 17 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+136 characters)
Article
Patent abstract
Administration of a mAb that specifically binds IL-1α is useful for treating tumor-associated diseases in human subjects.
Edits on 2 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
John Simard0
Edits on 21 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 27 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
102942960
Date of Patent
May 21, 2019
0Patent Application Number
132154640
Date Filed
August 23, 2011
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 26 Jan, 2022
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 10294296 Treatment for neoplastic diseases
Infobox
Is a
Patent jurisdiction
Patent number
10294296
Date of patent
May 21, 2019
Patent application number
13215464
Date Filed
August 23, 2011
Patent primary examiner
Find more entities like US Patent 10294296 Treatment for neoplastic diseases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
